Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

60 participants · First posted May 30, 2017

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

180 participants · First posted Aug 18, 2021

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

225 participants · First posted Jul 21, 2020

Naltrexone(Contrave, Embeda, Vivitrol, Mysimba)

C₂₀H₂₃NO₄ · Rx

Fluoxetine/Naltrexone

Naltrexone/Acetaminophen

成都德莱生物科技有限公司

Supernus Pharmaceuticals

United States

Aytu BioPharma

Spark Biomedical Completes Enrollment in Two Pivotal Neurostimulation Trials for Opioid Use Disorder and Neonatal Withdrawal

BioCorRx Secures U.S. Patent for Biodegradable Naltrexone Implant Technology

Soleno Therapeutics Publishes Pivotal VYKAT XR Study Results in Leading Endocrinology Journal